Formulary Subgroup - BNF Chapters

The documents on this page will be subject to updates. Please refresh your browser to ensure that you are looking at the latest versions.

The GM Formulary includes medicines and technologies for use in adult patients only. For information relating to prescribing in children prescribers should refer to the BNF and BNFc.
 

The GMMMG formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. Adherence to the formulary is strongly recommended by GMMMG and this formulary supersedes all local formularies.  The formulary is applicable to new initiations and should meet the needs of the majority of adult patients. Further information can be found in the ‘Frequently Asked Questions’ document.

Thirteen chapters of the formulary are now available and the chapters and subsections are listed below.  A full, open consultation with our key stakeholders, including the pharmaceutical industry, patient groups and clinicians via the open-access GMMMG website has been undertaken. As a result, a large number of comments have been considered and discussed and the chapters updated as required.  All finalised chapters will continue to be subject to an ongoing review process and will be updated on a regular basis via the website. If you have any requests, changes or removals please go to the Formulary Requests section.

The Formulary subgroup reviews NICE TAs, MHRA Drug Safety Updates and NTS recommendations every month.

NICE approved medicines:
All medicines recommended for use in the NHS in a NICE Technology Assessment are approved for use in Greater Manchester..